Characteristics | Total (n = 52) | R1 (n = 35) | R0 (n = 17) | P value |
---|---|---|---|---|
Age (mean, years) | 51.0 ± 18.7 | 51.9 ± 17.3 | 49.2 ± 21.9 | 0.641 |
Gender | 0.769 | |||
Male | 28 (53.8) | 18 (51.4) | 10 (58.8) | |
Female | 24 (46.2) | 17 (48.6) | 7 (41.2) | |
Duration of follow-up (month) | 67.9 ± 44.9 | 62.6 ± 41.6 | 78.8 ± 50.6 | 0.226 |
Adjuvant chemotherapy | 4 (7.7) | 2 (5.7) | 2 (11.8) | 0.589a |
Size (diameter) | 1.000a | |||
≤ 5 cm | 5 (9.6) | 3 (8.6) | 2 (11.8) | |
> 5 cm | 47 (90.4) | 32 (91.4) | 15 (88.2) | |
Location (extremity) | 0.031a | |||
Upper | 7 (13.5) | 2 (5.7) | 5 (29.4) | |
Lower | 45 (86.5) | 33 (94.3) | 12 (70.6) | |
FNCLCC Grade | 0.096 | |||
Grade I | 15 (20.6) | 13 (37.1) | 2 (11.8) | |
Grade II | 21 (40.4) | 11 (31.4) | 10 (58.8) | |
Grade III | 16 (30.8) | 11 (31.4) | 5 (29.4) | |
Local recurrence | 10 (19.2) | 4 (11.4) | 6 (35.3) | 0.062a |
Distant recurrence | 21 (40.4) | 14 (40.0) | 7 (41.2) | 0.935 |